Literature DB >> 27306572

Somatic mutation of a candidate tumour suppressor MGA gene and its mutational heterogeneity in colorectal cancers.

Yun Sol Jo1, Min Sung Kim1, Nam Jin Yoo1, Sug Hyung Lee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27306572     DOI： 10.1016/j.pathol.2016.04.010

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  6 in total

1.  Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.

Authors:  Armin R Afshar; Melike Pekmezci; Michele M Bloomer; Nicola J Cadenas; Meredith Stevers; Anuradha Banerjee; Ritu Roy; Adam B Olshen; Jessica Van Ziffle; Courtney Onodera; W Patrick Devine; James P Grenert; Boris C Bastian; David A Solomon; Bertil E Damato
Journal:  Ophthalmology       Date:  2019-12-12       Impact factor: 12.079

Review 2.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

3.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

4.  Mga Modulates Bmpr1a Activity by Antagonizing Bs69 in Zebrafish.

Authors:  Xiaoyun Sun; Ji Chen; Yanyong Zhang; Mumingjiang Munisha; Scott Dougan; Yuhua Sun
Journal:  Front Cell Dev Biol       Date:  2018-09-28

5.  Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients.

Authors:  Takahiko Koyama; Kahn Rhrissorrakrai; Laxmi Parida
Journal:  BMC Cancer       Date:  2019-02-01       Impact factor: 4.430

6.  Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.

Authors:  Johanne I Weberpals; Trevor J Pugh; Paola Marco-Casanova; Glenwood D Goss; Natalie Andrews Wright; Prisni Rath; Jonathon Torchia; Alexander Fortuna; Gemma N Jones; Martine P Roudier; Laurence Bernard; Bryan Lo; Dax Torti; Alberto Leon; Kayla Marsh; Darren Hodgson; Marc Duciaume; William J Howat; Natalia Lukashchuk; Stanley E Lazic; Doreen Whelan; Harmanjatinder S Sekhon
Journal:  Cancer Med       Date:  2021-04-03       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.